Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

5029 total record number 57 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 40 out of 503
5029 citations found

Product: ULTRA PURE LPS from Escherichia coli O111:B4

  • mal-Free Recombinant Murine IL-4 PeproTech AF-214-14 Animal-Free Recombinant Murine IL-10 PeproTech AF-210-10 ULTRA PURE LPS from Escherichia coli O111:B4 List Biological Laboratories 421

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

  • ts, Tujunga CA) on a homeothermic hea+ng blanket to maintain body temperature of 370 C. The dorsal brainstem was exposed via blunt dissec+on and, following removal of the meningeal membrane, the vagal trigone was exposed. Then, five microinjec+ons of Cholera Toxin B (CTB; List Labs, Campbell, CA, 0.5% in dis+lled water; 60nl per injec+on) were made using a glass pipeEe aEached to a Picospritzer (Toohey Co., Fairfield NJ) into the rostrocaudal extent of the DMV at co-ordinates (in mm) rostro-caudal 0.0-0.6mm from calamus scriptorius, medio-lateral +0.3-0.4 from the midline; dorso-ventral -0.6-0.65 from the surface of the brainstem Injec+ons were made

??????????????????

???, ;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

  • ??????????? ?????? 1% Fluorogold(FG; Fluorochrome, Englewood, CO, USA),??? 0.1 M PB ????? 1% ???? B ??????(CTb; List Biological

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • d 2 post-immunisation, mice received an intraperitoneal injection of 200 ng pertussis toxin in 200 ?L PBS (List Biological Laboratories, #179A). The mice were monitored and scored daily for EAE symp

Product: Pertussis Toxin from B. pertussis (in Glycerol)

  • 193 at concentrations of 0.1, 1, and 5 ?M in a fresh medium was added to the cells. All reactions, including controls without the inhibitors, contained 0.05% DMSO. After 30 minutes of incubation at 37°C under normal cell culturing conditions, pertussis holotoxin (List Biological Laboratories Inc., 179A) was added to the cells at concentrations of 10 or 100 ng/ml. Cells were then incubated for an additional 2 hours, placed on ice,

Product: LIPID A monophosphoryl from Salmonella minnesota R595

  • Labelling of Lipid A. One mg of commercially obtained lipid A (List Laboratories, Campbell, CA) or lipid A derived from Escherichia coli K 235 LPS by the method described by Galanos et al

Product: LIPID A monophosphoryl from Salmonella minnesota R595

  • 401 from List Labs). LPS was directly diluted and aliquoted to 100 ?g/ml stock solutions in UP water. MPLA was first diluted in 10% DMSO and then aliquoted to 100 ?g/ml

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • sis toxin was administered on days 0 and 2 (100 ng/mouse, i.p) (List Biological Laboratories, Campbell, CA, USA). Sera were collected on day 0 and day 21 post-immunization at termination

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • 2.1.2 Study II: Examination of the contribution of neuroinflammatory processes such as
    BBB leakage and focal inflammation to changes in mechanical properties

    For in vivo MRE and MRI experiments adoptive transfer EAE was induced in 21 SJL mice (female, 9-12 weeks, Janvier, SAS, France, registration number G106/19) by the transfer of myelin proteolipid protein (PLP)-reactive lymphocytes. SJL mice were used as the animal strain of choice to induce EAE (active and adoptive transfer), as they display a high disease susceptibility after induction. PLP-reactive lymphocytes were obtained from 22 donor mice, which were actively immunized as previously described (31, 34) using 200 mg of the myelin peptide PLP139-151 emulsified with 200 ml complete Freund´s adjuvant (Thermo Fischer Scientific, United States) and 800 mg Mycobacterium tuberculosis
    H37Ra (Difico, United States). As described in (31), on days 0 and 2 postimmunization (p.i.), 250 ng pertussis toxin (List Biological Laboratories, United States) was injected intraperitoneally. Donor animals were sacrificed on day 10 p.i., axillary and inguinal lymph nodes were collected and cells cultured as described (35). Cells were harvested after 4 days in culture with RPMI 1640 medium (supplemented with 2 mM L-glutamine, 100 units/ml penicillin, 100 mg/ml streptomycin and 10 % fetal bovine serum) (Gibco, Thermo Fischer Scientific) containing 12.5 mg/ml PLP. Into each of the 21 recipient mice 30 million cells were intraperitoneally injected. …

    Author did not specify which List Labs Pertussis Toxin was utilized. List Labs provides the following Pertussis Toxin products:
    Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer
    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)
    Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)